I have wonderful news to share with you today. I am extremely proud to announce that the FDA has just approved our groundbreaking MiniMed 670G system – the first hybrid closed loop system in the world! This approval is a significant milestone in the history of diabetes management, and a culmination of many years
Hypoglycemia (low blood glucose) can be very dangerous and is one of the most frightening situations for people with diabetes – particularly during the night when an estimated 57% of people with type 1 diabetes experience a low at least once.[i] Not to mention it impacts their quality of life and takes time out
I am thrilled to announce the U.S. launch of the MiniMed 630G system with SmartGuard technology – our most advanced pump platform for people with diabetes in the country. This latest innovation was developed through a collaborative process with the patient community, who provided feedback on features that matter most to people with diabetes.
This post was inspired by an interview with Shahram Ebadollahi, PhD,Vice President, Innovation & Chief Science Officer at IBM Watson Health. In part I of the series, we learned how cognitive computing can play a role in everyday life for people with diabetes, but were left wondering what impact cognitive computing in diabetes management
Our industry is changing and evolving at an unprecedented rate, which is why it is important for us to set the pace of innovation across several areas. Disruptive Innovation for Type 1 Diabetes Recently, we shared pivotal trial results for the first hybrid closed loop system. I am extremely excited to announce today that
This article was inspired by an interview with Shahram Ebadollahi, PhD, Vice President, Innovation & Chief Science Officer at IBM Watson Health. This is part one in a two-part series on cognitive computing in diabetes management. If data bytes were grains of rice, your body would generate enough during your life to cover Manhattan.[i]
For people with type 1 diabetes, the day-to-day management can be a full-time job. We have been working toward the development of an artificial pancreas, focusing on shifting the burden of managing diabetes from the person to the system. Listen to my podcast with The Bio Report to learn more about the progress we’ve
In January 2016, we signed a long-term partnership with the Chengdu municipal government to provide better diabetes management for the growing – and underserved – diabetes population in China. So, why China? According to the International Diabetes Federation, there are 415 million people in the world living with diabetes.[i] That’s a staggering number. Twenty-five
I am excited to announce Diabetes, Obesity and Metabolism, an international, peer-reviewed journal, recently published the results of the continuation phase of our OpT2mise study, which could redefine the standard of care and expand access to insulin pump therapy for the growing population of insulin-dependent people with type 2 diabetes with poor glucose control.